Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Total 13F shares
-
5,217,362
-
Share change
-
-483,890
-
Total reported value
-
$900,383,525
-
Put/Call ratio
-
59%
-
Price per share
-
$172.62
-
Number of holders
-
226
-
Value change
-
-$80,539,126
-
Number of buys
-
79
-
Number of sells
-
120
Institutional Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q2 2021
As of 30 Jun 2021 FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) had 226 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 5,217,362 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, UBS Group AG, LPL Financial LLC, Raymond James Financial Services Advisors, Inc., ROYAL BANK OF CANADA, RAYMOND JAMES & ASSOCIATES, OSAIC HOLDINGS, INC., and COMMONWEALTH EQUITY SERVICES, LLC.
This table shows 227 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.